14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ZEPP vs VIOT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Viomi Technology Co., Ltd (VIOT) is the stronger overall head-to-head candidate over Zepp Health Corporation (ZEPP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ZEPP carries a Unified Composite Score of 45.7/100 (HOLD) at $2.31 (3.1x Forward P/E, -12.6% operating margin), whereas VIOT carries 50.8/100 (HOLD) at $1.25 (7.3x Forward P/E, -2.4% operating margin).
Growth vs. Quality Trade-Off: VIOT earns the overall head-to-head edge with a stronger Unified Composite Score (50.8/100 HOLD vs. ZEPP 45.7/100 HOLD) and 0.51β · 61% Vol risk profile, whereas ZEPP leads top-line expansion (+6.9% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: ZEPP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4); meanwhile VIOT trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 40.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZEPP vs VIOT. Trailing 12-month operating profitability (ZEPP -12.6% vs VIOT -2.4%) and valuation multiples (ZEPP 3.1x vs VIOT 7.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Furnishings, Fixtures & Appliances value chain with $84.4M market capitalization and -2.4% operating margin.
OpEx & R&D Reinvestment26.2% of Rev ($443M)
90D Engineering Disclosures0 Published
Investor FAQ ZEPP vs VIOT Key Questions & Quantitative Answers
As of Nov 20, 2026, Viomi Technology Co., Ltd (VIOT) is the stronger overall head-to-head candidate over Zepp Health Corporation (ZEPP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ZEPP carries a Unified Composite Score of 45.7/100 (HOLD) at $2.31 (3.1x Forward P/E, -12.6% operating margin), whereas VIOT carries 50.8/100 (HOLD) at $1.25 (7.3x Forward P/E, -2.4% operating margin). Growth vs. Quality Trade-Off: VIOT earns the overall head-to-head edge with a stronger Unified Composite Score (50.8/100 HOLD vs. ZEPP 45.7/100 HOLD) and 0.51β · 61% Vol risk profile, whereas ZEPP leads top-line expansion (+6.9% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: ZEPP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4); meanwhile VIOT trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 40.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
VIOT leads the Growth & Scale pillar: ZEPP posts +6.9% YoY revenue growth and -68.1% YoY earnings growth on $276M TTM revenue (38.6% gross margin, -12.6% operating margin), compared with VIOT at -49.9% YoY revenue growth and -62.3% YoY earnings growth on $1.69B TTM revenue (23.8% gross margin, -2.4% operating margin). On trailing 12-month operating scale, ZEPP generates $276M in USD-normalized revenue versus $1.69B for VIOT. In operating R&D and SG&A reinvestment, ZEPP deploys 51.2% of Rev ($141M) (0 90-day corporate R&D disclosures) versus 26.2% of Rev ($443M) (0 disclosures) for VIOT.
ZEPP screens cheaper on headline valuation multiples. ZEPP trades at 3.1x Forward P/E, 3.1x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-11.0% EBITDA margin), whereas VIOT trades at 7.3x Forward P/E, 7.3x Trailing P/E, 0.73x PEG, and N/M EV/Revenue (0.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ZEPP (-21.2% ROE) versus VIOT (-0.4% ROE) capital efficiency.
In options market volatility and institutional positioning, ZEPP carries 124.3% implied volatility (94th %ile, Extreme (>80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.12β · 68% Vol realized risk). By comparison, VIOT carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.51β · 61% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.